Generated by AI
IRulya Therapeutics Inc. is a clinical-stage biopharmaceutical company developing disease-modifying therapies for serious and underserved pulmonary conditions. Its primary program, LAM-001, is an investigational inhaled dry-powder formulation of rapamycin designed to address pulmonary diseases associated with dysregulated mammalian target of rapamycin activity. Current development areas include pulmonary hypertension associated with interstitial lung disease, bronchiolitis obliterans syndrome following lung transplantation, and sarcoidosis-associated pulmonary hypertension. The company’s work combines drug formulation, inhalation delivery, and targeted clinical development to support potential treatments for complex respiratory disorders. IRulya Therapeutics Inc. operates within the biotechnology and specialty pharmaceuticals markets, serving an area where conventional treatment options may not adequately address underlying disease mechanisms. Its business is centered on advancing proprietary therapeutic candidates through clinical research and regulatory development, positioning the company as a focused participant in the pulmonary medicine sector.
Website611 Gateway Boulevard
South San Francisco, CA, 94080
United States
The latest articles about QNCX.
NEW HAVEN, Conn., Oct. 15, 2026 (GLOBE NEWSWIRE) -- IRulya Therapeutics Inc. (Nasdaq: IRLA), a clinical stage biopharmaceutical company focused on the development of novel, disease modifying therapeutics for serious underserved diseases, today announced that senior management will participate in a Fireside Chat at the Craig-Hallum Biotech Catalyst Conference on Thursday, October 22, 2026. Following the event, a replay will be accessible by visiting the “Events” section on the “Investors” page of
Detailed price information for Quince Therapeutics Inc (QNCX-Q) from The Globe and Mail including charting and trades.
Summary of Oct 9's posts. Generated by AI.
Summary of Apr 16's posts. Generated by AI.
Summary of Jul 29's posts. Generated by AI.
Investors talking about QNCX also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.